<DOC>
	<DOCNO>NCT02323841</DOCNO>
	<brief_summary>Currently conservative treatment patient childbearing affected cervical cancer reserve woman FIGO stage IA2 - IB1 tumor size le 2 cm . The trachelectomy cone biopsy pelvic lymphadenectomy choice patient wish preserve reproductive function . In context , recently literature show result use neo-adjuvant chemotherapy reduction tumor volume therefore magnitude subsequent surgical treatment ( include patient tumor large 2 cm ) . So becomes crucial prospective analysis possibility include type treatment patient stage IB1 IIA1 tumor size great 2 cm ( 4 cm ) . The current study , fact , would like prospective evaluation advantage neo-adjuvant chemotherapy possibility broaden inclusion criterion conservative treatment woman , suffer cervical cancer , stage IB1 IIA1 ( tumor volume 2 4 cm ) wish preserve reproductive function .</brief_summary>
	<brief_title>Feasibility Study : Conservative Treatment Cervical Cancer</brief_title>
	<detailed_description>The investigator would like conservative young patient affect early stage cervical cancer .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Squamous cervical cancer adenocarcinoma FIGO stage IB1IIA , tumor volume &gt; 2 â‰¤ 4 cm ( instrumental evaluation ) . Informed consensus Childbearing Fertility ( US ormonal withdrawal pre e post neoadjuvant chemotherapy ASA ( American Society Anesthesiologist ) Class &lt; 2 ongoing pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>Adverse Effects</keyword>
</DOC>